| Dr Abbie M Tolliver, MD | |
|
8607 E Us Highway 36 Ste 100, Avon, IN 46123-7960 | |
| (317) 745-5403 | |
| Not Available |
| Full Name | Dr Abbie M Tolliver |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 19 Years |
| Location | 8607 E Us Highway 36 Ste 100, Avon, Indiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437318706 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 01065136A (Indiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hendricks Regional Health | Danville, IN | Hospital |
| Iu Health West Hospital | Avon, IN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| American Health Network Of Indiana Llc | 9830093533 | 212 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
In a peer-reviewed commentary published in npj Digital Medicine, experts from Regenstrief Institute, Mayo Clinic and The Pew Charitable Trusts write that matching patient records from disparate sources is not only achievable, but fundamental to stem the tide of the current pandemic and allow for fast action for future highly contagious viruses.
Apotex Inc. today announced that the second shipment of Apo-TriAvir, the generic triple-combination AIDS drug produced to simplify AIDS treatment in developing countries, was leaving for Rwanda, the only country to have benefited from Canada's Access to Medicines Regime (CAMR).
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
› Verified 3 days ago
| Entity Name | American Health Network Of Indiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831236272 PECOS PAC ID: 9830093533 Enrollment ID: O20031124000691 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
In a peer-reviewed commentary published in npj Digital Medicine, experts from Regenstrief Institute, Mayo Clinic and The Pew Charitable Trusts write that matching patient records from disparate sources is not only achievable, but fundamental to stem the tide of the current pandemic and allow for fast action for future highly contagious viruses.
Apotex Inc. today announced that the second shipment of Apo-TriAvir, the generic triple-combination AIDS drug produced to simplify AIDS treatment in developing countries, was leaving for Rwanda, the only country to have benefited from Canada's Access to Medicines Regime (CAMR).
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Abbie M Tolliver, MD 8607 E Us Highway 36 Ste 100, Avon, IN 46123-7960 Ph: (317) 745-5403 | Dr Abbie M Tolliver, MD 8607 E Us Highway 36 Ste 100, Avon, IN 46123-7960 Ph: (317) 745-5403 |
News Archive
The Associated Press examines the debate over the future of the Affordable Medicines Facility-malaria (AMFm), after the recent release of two papers evaluating the program's effectiveness. AMFm was established in 2010 as "a pilot project to subsidize artemesinin combination drugs, the most effective malaria treatment," the AP writes, noting the $460 million program is managed by the Global Fund to Fight AIDS, Tuberculosis and Malaria.
In a peer-reviewed commentary published in npj Digital Medicine, experts from Regenstrief Institute, Mayo Clinic and The Pew Charitable Trusts write that matching patient records from disparate sources is not only achievable, but fundamental to stem the tide of the current pandemic and allow for fast action for future highly contagious viruses.
Apotex Inc. today announced that the second shipment of Apo-TriAvir, the generic triple-combination AIDS drug produced to simplify AIDS treatment in developing countries, was leaving for Rwanda, the only country to have benefited from Canada's Access to Medicines Regime (CAMR).
XenoPort, Inc. announced today that it has initiated a Phase 2b clinical trial of arbaclofen placarbil (AP), also known as XP19986, in patients with gastroesophageal reflux disease (GERD) who remain symptomatic despite treatment with a proton pump inhibitor (PPI). The trial is a multi-center, randomized, double-blind, placebo-controlled study designed to assess the efficacy and safety of AP as adjunctive therapy to PPIs.
A diet high in saturated fat is a key contributor to type 2 diabetes, a major health threat worldwide. Several decades ago scientists noticed that people with type 2 diabetes have overly active immune responses, leaving their bodies rife with inflammatory chemicals.
› Verified 3 days ago
Bhasker Reddy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 N Ronald Reagan Parkway, Suite 206, Avon, IN 46123 Phone: 317-272-8050 Fax: 317-272-8051 | |
Namrata Shah, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy Ste B1500, Avon, IN 46123 Phone: 317-217-2244 Fax: 317-217-2249 | |
Graham D Dellinger, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-217-2888 Fax: 317-217-2999 | |
Caitlin M Baxter, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 1111 Ronald Reagan Pkwy, Avon, IN 46123 Phone: 317-962-5820 Fax: 317-962-3916 | |
Dr. Stephen H Pollom, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1115 Ronald Reagan Pkwy, Ste 318, Avon, IN 46123 Phone: 317-217-2600 Fax: 317-217-2606 | |
Dr. David Lee Hyslop, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 6013 Yellow Birch Ct, Avon, IN 46123 Phone: 317-838-7096 | |
Michaela A Besold, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8244 E Us Highway 36, Suite 1320, Avon, IN 46123 Phone: 317-272-7519 Fax: 317-272-3661 |